Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma [NA]

View source ↗

Summary

A completed clinical trial evaluated Alphagan (brimonidine) for its effects on retinal blood flow autoregulation and motion detection in patients with normal te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alphagan (brimonidine)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Glaucoma | NA | Status: COMPLETED | Results posted: 2016-10-27